We break down five of the week's most important news stories.
For further analysis, listen to the latest episode of The FirstTake podcast here.
OX40 comes to the fore as a new target in atopic dermatitis
More wind in EQRx's sails
MorphoSys makes a move
To read more Friday Five articles, click here.